Cargando…

25380 Cholecystokinin-B Receptor -Mediates Growth of Hepatocellular Carcinoma

ABSTRACT IMPACT: Cholecystokinin-B Receptor -Mediates Growth of Hepatocellular Carcinoma with the use proglumide. Proglumide is a non-selective antagonistic drug therefore, strategies that block signaling at the CCK-BR may provide to be a novel therapeutic option for Hepatocellular Carcinoma treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gay, Martha Dee, Safronenka, Anita, Cao, Hong, Tucker, Robin, Shivapurkar, Narayan, Smith, Jill P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Basic Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827854/ http://dx.doi.org/10.1017/cts.2021.427

Ejemplares similares

4119 Cholecystokinin (CCK) Receptor Antagonist Reverses Nonalcoholic Steatohepatitis (NASH) by Reducing Hepatic Macrophages and Inflammatory Cytokines
por: Gay, Martha, et al.
Publicado: (2020)

A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma
por: Tucker, Robin D., et al.
Publicado: (2019)

Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment
por: Malchiodi, Zoe X., et al.
Publicado: (2021)

Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma
por: Shivapurkar, Narayan, et al.
Publicado: (2023)

2297: Dietary fat stimulates growth of pancreatic cancer growth through the cholecystokinin receptor
por: Nadella, Sandeep, et al.
Publicado: (2018)

Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer
por: Burks, Julian, et al.
Publicado: (2018)

4121 The beneficial, anti-fibrotic effects of chemokine receptor 2 and 5 antagonists on fat-exposed mouse primary hepatic stellate cells (pHSCs)
por: Kruger, Annie J., et al.
Publicado: (2020)

Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non‐alcoholic Steatohepatitis
por: Rabiee, Atoosa, et al.
Publicado: (2022)

Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic
por: Jolly, Gurbani, et al.
Publicado: (2023)

Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome
por: Gay, Martha D., et al.
Publicado: (2022)

Expression and functional study of cholecystokinin-A receptors on the interstitial Cajal-like cells of the guinea pig common bile duct
por: Xu, Dan, et al.
Publicado: (2023)

Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence
por: Wen, Di, et al.
Publicado: (2012)

Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas
por: Smith, Jill P., et al.
Publicado: (2021)

The Excitatory Effect of Cholecystokinin on Colonic Motor Function via Cholecystokinin(1) Receptor
por: Jun, Jae Yeoul
Publicado: (2011)

Cholecystokinin Activation of Cholecystokinin 1 Receptors: a Purkinje Cell Neuroprotective Pathway
por: Orr, Harry T.
Publicado: (2022)

Trypsin inhibitor from tamarindus indica L. seeds reduces weight gain and food consumption and increases plasmatic cholecystokinin levels
por: do Nascimento Campos Ribeiro, Joycellane Alline, et al.
Publicado: (2015)

Dual pathways of internalization of the cholecystokinin receptor
Publicado: (1995)

Serum cholecystokinin levels can be a predictive factor for difficult cholecystectomy: Decreased cholecystokinin receptor levels
por: Utku Yılmaz, Tonguç, et al.
Publicado: (2022)

Sensitivity of cholecystokinin receptors to membrane cholesterol content
por: Desai, Aditya J., et al.
Publicado: (2012)

Permanent Photodynamic Activation of the Cholecystokinin 2 Receptor
por: Tang, Wen Zhu, et al.
Publicado: (2020)

Cholecystokinin Receptor Antagonist Suppresses Melanoma Growth by Inducing Apoptosis of Tumor Cells
por: Funakoshi, Atsuko, et al.
Publicado: (2022)

Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways
por: Zheng, Piao, et al.
Publicado: (2022)

2466 MicroRNA-451: A potential key player in the development of diabetic nephropathy in an insulin resistant mouse model
por: Fluitt, Maurice B, et al.
Publicado: (2018)

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma
por: Clawson, Gary A., et al.
Publicado: (2017)

Cholecystokinin and the hormone concept
por: Rehfeld, Jens F
Publicado: (2021)

Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells
por: Mjønes, Patricia, et al.
Publicado: (2017)

Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide
por: Yang, Yin, et al.
Publicado: (2018)

Structural insights into human brain–gut peptide cholecystokinin receptors
por: Ding, Yu, et al.
Publicado: (2022)

Cholecystokinin-like peptide mediates satiety by inhibiting sugar attraction
por: Guo, Di, et al.
Publicado: (2021)

Cholecystokinin induces crowing in chickens
por: Shimmura, Tsuyoshi, et al.
Publicado: (2019)

Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation
por: Costa, Alessia, et al.
Publicado: (2021)

Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve
por: Luyer, Misha D., et al.
Publicado: (2005)

Cholecystokinin A Receptor (CCKAR) Gene Variation Is Associated with Language Lateralization
por: Ocklenburg, Sebastian, et al.
Publicado: (2013)

Role of cholecystokinin receptor-A gene polymorphism in development of functional dyspepsia
por: Singh, Rajan, et al.
Publicado: (2014)

Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue
por: Roy, Jyoti, et al.
Publicado: (2016)

Ligand recognition and G-protein coupling selectivity of cholecystokinin A receptor
por: Liu, Qiufeng, et al.
Publicado: (2021)

The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management
por: Bernard, Amandine, et al.
Publicado: (2021)

Discovery of the cyclotide caripe 11 as a ligand of the cholecystokinin-2 receptor
por: Taghizadeh, Mohammad Sadegh, et al.
Publicado: (2022)

Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis
por: Ballaz, Santiago J., et al.
Publicado: (2021)

The Synergistic Roles of Cholecystokinin B and Dopamine D(5) Receptors on the Regulation of Renal Sodium Excretion
por: Jiang, Xiaoliang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1jkrjpso8vbuij93rrj1utj4or